Pharma funds rally: How to pick right one based on portfolio, risk, costs
Last Update Date: 05-10-2026
Published by Business Standard
Abhishek Kumar's role: Quoted
Abhishek Kumar explained how pure pharma exposure differs from broader healthcare and the trade-offs of large-cap, mid and small-cap and global tilts. He suggested using three- and five-year rolling returns and maximum drawdown.
More of Abhishek's views on mutual funds
The article looks at choosing a pharma or healthcare mutual fund after the category's recent rally. It compares pharma-focused and broader healthcare funds, large-cap and mid or small-cap tilts, domestic and global exposure, and active and passive approaches. It also suggests judging funds on rolling returns, drawdowns, costs, turnover and fund size.
Publisher source
Pharma funds rally: How to pick right one based on portfolio, risk, costs